1[1] Lancaster SG,Todd PA.Lisinopril:A preliminary review of its pharmacodynamic and pharmacokinetic properties,and therapeutic use in hypertension and congestive heart failure[J].Drugs,1988,35(6):646-669.
2[2] Neutel JM,Frishman WH,Oparil S,et al.Comparison of tel-misartan with linsinopril in patients with mild-to-moderate hypertension[J].Am J Ther,1999,6(3):161-166.
1[3]Report of a WHO Expert Committee,Arterial hypertension[R].WHO Technical Report Series,Geneva,1978:628.
2[4]Friedewald WT,Levy RI,Fredrickson DS.Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge[J].Clin Hem,1972,18:499-502.
3[7]Austin MA,Brunzell JD,Fitch WL,et al.Inheritance of low density lipoprotein Subclass patterns in familial combined hyperlipidemia[J].Arteriosclerosis ,1990,10:520-530.
4[8]Frossard PM,Obineche EN,Lestringant GG.Association of apolipoprotein B gene marker with essential hypertension[J].Hypertension,1999,33(4):1052-1056.
5[9]Parthasarathy S,Barnett J,Fong LG,et al.High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein[J].Biochim biophys Acta,1990,1044:275-283.
6[10]Khoo JC,Miller E,Mcloughin P,et al.Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-Ⅰ[J].J Lipid Res,1990,31: 645-652.
7[11]Lardinois CK,Neuman SL.The effects of antihypertensive agents on serum lipids and lipoproteins[J].Arch Intern Med,1988,48:1280-1288.
8[12]Weidmann P,Ferrier C,Saxenhofer H,et al.Serum lipopreteins during treatment with antihypertensive drugs[J].Drugs,1988,35(Suppl 6):118-134.
9[13]Costa FV,Borghi C,Mussi A,et alHypolipidemic effects of longterm antihypertensive treatment with captopril:a prospective study[J].Am J Med,1988,84(3A):159-161.
